Table 4.
Largest Published Registries of Retrograde CTO PCI
| Authors | No. of Retrograde Cases | Study Period | Initial Retrograde Approach, % | Initial Retrograde Technical Success, % | Use of Reverse CART, % | Overall Technical Success, % | Overall MACE Rate, % |
|---|---|---|---|---|---|---|---|
| Yamane et al74 | 378 | 2009 | 75 | 70.4 | 42.5 | 83.6 | 0.5 |
| Tsuchikane et al75 | 801 | 2009–2010 | 67 | 71.2 | 55.2 | 84.8 | 1.6 |
| Karmpaliotis et al76 | 462 | 2006–2011 | 46 | 83.4 | 47.2 | 81.4 | 2.6 |
| Galassi et al77 | 1582 | 2008–2012 | 76 | 83.2 | 16.0 | 75.3 | 0.8 |
| Karmpaliotis et al78 | 539 | 2012–2015 | 46 | 82.1 | 62.2 | 84.8 | 4.3 |
CART indicates controlled antegrade and retrograde subintimal tracking; CTO, chronic total occlusion; MACE, major adverse cardiac event; and PCI, percutaneous coronary intervention.